Related Experiment Video
Updated: Jun 20, 2026
06:19
Chinese Herbal Retention Enema for the Treatment of Ulcerative Colitis
Published on: May 16, 2025
Treatment of severe ulcerative colitis: differences in elderly patients?
Stephan R Vavricka1, Gerhard Rogler
1Division of Gastroenterology and Hepatology, University Hospital Zurich, CH-8091 Zurich, Switzerland. stephan.vavricka@usz.ch
Digestive Diseases (Basel, Switzerland)
|September 30, 2009
Summary
Late-onset ulcerative colitis (UC) affects elderly patients, posing unique treatment challenges. Management requires careful consideration of therapies like steroids, cyclosporine, infliximab, and surgery, especially in older adults.
Area of Science:
- Gastroenterology
- Geriatric Medicine
- Internal Medicine
Background:
- Ulcerative colitis (UC) can present late in life, with 10% of patients experiencing their first flare between ages 60-70.
- While disease course and management principles are similar to younger patients, elderly individuals present distinct therapeutic challenges.
- Severe, untreated ulcerative colitis remains a significant concern in the elderly, unlike in middle-aged populations.
Purpose of the Study:
- To review the management of ulcerative colitis in geriatric populations.
- To highlight the specific challenges and considerations for therapy choice in elderly patients with ulcerative colitis.
- To discuss the efficacy and limitations of various treatment modalities, including medical and surgical options.
Main Methods:
- Review of current evidence and established treatment guidelines for ulcerative colitis.
- Analysis of therapeutic options including corticosteroids, cyclosporine, infliximab, tacrolimus, and surgery.
- Consideration of patient-specific factors such as age, comorbidities, and disease severity in treatment selection.
Main Results:
- Corticosteroid therapy shows limited response rates (40%), with a substantial proportion (30%) progressing to colectomy.
- Cyclosporine is effective salvage therapy for steroid-refractory patients but carries risks in the elderly and frail, often only delaying colectomy.
- Infliximab is suitable for less severe cases, while surgery remains the definitive treatment, with timing being critical.
Conclusions:
- Elderly patients with ulcerative colitis require tailored therapeutic strategies, balancing efficacy with safety concerns.
- Careful patient selection and close collaboration between gastroenterologists and surgeons are crucial for optimal outcomes.
- While medical therapies have roles, surgical intervention remains a definitive treatment option for ulcerative colitis, particularly in complex or refractory cases.
Related Concept Videos
01:29Drugs for Treatment of Ulcerative Colitis in IBD
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide generation.
01:21Inflammatory Bowel Disease V: Surgical Management
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
01:21Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2 (COX-2),...
01:29Inflammatory Bowel Disease IV: Pharmacological Management
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
01:26Peptic Ulcer Disease IV: Management
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...